Patents by Inventor D. Gordon

D. Gordon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE
    Publication number: 20150216917
    Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
    Type: Application
    Filed: April 17, 2015
    Publication date: August 6, 2015
    Inventors: LEE A. JONES, COURTNEY R. JONES, EDWIN J. HLAVKA, RYAN D. GORDON
  • EXERCISE DEVICE PROVIDING USER DEFINED PEDAL MOVEMENTS
    Publication number: 20150202489
    Abstract: An exercise device for performing a variety of movement patterns is provided, having an upper link pivotally mounted to a lower leg link and a foot support on a distal end of the lower leg link. A first transfer system is movably coupled to a frame and including a first transfer member coupled to the first upper leg link and a second transfer member coupled to the second upper leg link, thereby enabling substantially reciprocating motion of the first leg link relative to the second leg link. A second transfer system is also provided and may be movably coupled to the frame and including a pair of third transfer members coupled to each of a pair of fourth transfer members by way of each of a pair of transfer couplings, each movably mounted to the frame.
    Type: Application
    Filed: February 2, 2015
    Publication date: July 23, 2015
    Inventors: Joel D. Gordon, Kevin G. Abelbeck, Glenn D. Ross
  • Varied gait exercise device with anatomically aligned hip pivots
    Patent number: 9050491
    Abstract: An exercise device for performing a variety of movement patterns is provided, having upper right and left leg links pivotally mounted to lower right and left leg links respectively. The upper leg links are pivotally coupled to the frame. A foot support is provided on the distal end of the lower leg links. The device includes first and second transfer systems for coordinating movement of the right and left sets of upper and lower leg links. The first transfer system is movably coupled to the frame and includes a first transfer member coupled to the first upper leg link, a second transfer member coupled to the second upper leg link, and a pivot bar pivotally mounted to the frame between a first end and a second end thereof with the first end coupled to the first transfer member and the second end coupled to the second transfer member.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: June 9, 2015
    Assignee: Exerciting, LLC
    Inventors: Joel D. Gordon, Brad R. Olschansky, Scott M. Olschansky, Kevin G. Abelbeck, Glenn D. Ross
  • COMPRESSION-DISTRACTION SPINAL FIXATION SYSTEM
    Publication number: 20150080958
    Abstract: Compression-distraction spinal fixation systems, and methods of performing compression-distraction spinal fixation, are provided that include screw-rod constructs having a ratcheting mechanism. Bone screws of the screw-rod constructs can have a pawl that engages ratchet teeth on the rod of the screw-rod construct. The bone screw can be ratcheted along the length of the rod to apply distractive or compressive forces.
    Type: Application
    Filed: September 17, 2014
    Publication date: March 19, 2015
    Applicants: The Johns Hopkins University, NEURAXIS LLC
    Inventors: Ryan M. Kretzer, Bryan W. Cunningham, Jeffrey D. Gordon
  • MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE
    Publication number: 20150050246
    Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method may include a method of treating an infection. The method may comprise administering a microbiota restoration therapy composition to a patient with an infection. The microbiota restoration therapy composition may comprise a mixture of an effective amount of fecal microbiota and an effective amount of polyethylene glycol.
    Type: Application
    Filed: October 31, 2014
    Publication date: February 19, 2015
    Inventors: Lee A. Jones, Courtney R. Jones, Edwin J. Hlavka, Ryan D. Gordon
  • MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE
    Publication number: 20150044173
    Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
    Type: Application
    Filed: October 2, 2014
    Publication date: February 12, 2015
    Inventors: Lee A. Jones, Courtney R. Jones, Edwin J. Hlavka, Ryan D. Gordon
  • Type system for declarative data scripting language
    Patent number: 8949784
    Abstract: An efficient, logical and expressive type system is provided for flexibly defining types of a declarative programming language so that efficient and structurally compact data intensive applications can be generated. The type system supports the combination of refinement types and type membership expressions, as well as a top type that encompasses all valid values as members. With the type system, types can be expressed as intersections and/or unions of other types. Thus, types can be efficiently represented for a full range of types of data as may be found in real world data stores.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: February 3, 2015
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: David E. Langworthy, Gavin Bierman, Andrew D. Gordon, Donald F. Box, Bradford H. Lovering, Jeffrey C. Schlimmer, John D. Doty
  • Security language expressions for logic resolution
    Patent number: 8938783
    Abstract: A security language expresses assertions and authorization queries in a manner that facilitates logic resolution. In an example implementation, assertion syntax and authorization query syntax are described. In another example implementation, checks on the safety of assertions and authorization queries are described. In yet another example implementation, semantics rules are described.
    Type: Grant
    Filed: September 11, 2006
    Date of Patent: January 20, 2015
    Assignee: Microsoft Corporation
    Inventors: Moritz Y. Becker, Blair B. Dillaway, Cedric Fournet, Andrew D. Gordon
  • MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE
    Publication number: 20140363400
    Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
    Type: Application
    Filed: August 15, 2014
    Publication date: December 11, 2014
    Inventors: Lee A. Jones, Courtney R. Jones, Edwin J. Hlavka, Ryan D. Gordon
  • MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE
    Publication number: 20140363399
    Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
    Type: Application
    Filed: June 30, 2014
    Publication date: December 11, 2014
    Inventors: Lee A. Jones, Courtney R. Jones, Edwin J. Hlavka, Ryan D. Gordon
  • MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE
    Publication number: 20140363398
    Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
    Type: Application
    Filed: June 4, 2014
    Publication date: December 11, 2014
    Inventors: Lee A. Jones, Courtney R. Jones, Edwin J. Hlavka, Ryan D. Gordon
  • INTERSEGMENTAL MOTION PRESERVATION SYSTEM FOR USE IN THE SPINE AND METHODS FOR USE THEREOF
    Publication number: 20140309694
    Abstract: Medical devices and kits for dynamically stabilizing or preserving motion in a spine and limiting adjacent, non-adjacent, or isolated segment degeneration of the spine while providing a controlled, determinable range of motion at the treated site, as well as methods for surgical use of the system.
    Type: Application
    Filed: October 26, 2012
    Publication date: October 16, 2014
    Applicants: The Johns Hopkins University, Neuraxis Technologies, LLC.
    Inventors: Ryan M. Kretzer, Bryan W. Cunningham, Jeffrey D. Gordon
  • HETEROCYCLIC NUCLEAR HORMONE RECEPTOR MODULATORS
    Publication number: 20140179676
    Abstract: The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
    Type: Application
    Filed: December 20, 2013
    Publication date: June 26, 2014
    Applicant: ABBVIE INC.
    Inventors: Kevin P. Cusack, Thomas D. Gordon, Michael Z. Hoemann, David C. Ihle, Bin Li, Gloria Y. Lo Schiavo, Gagandeep K. Somal, Michael Friedman, Martin E. Hayes, Wouter Iwema Bakker
  • Tacrolimus For Improved Treatment Of Transplant Patients
    Publication number: 20140179731
    Abstract: An extended release oral dosage form comprising as active substance tacrolimus or a pharmaceutically active analogue thereof for a once daily immunosuppressive treatment of a patient in need thereof, preferable a kidney or liver transplant patient. The dosage form releases the active substance over an extended period of time. It also provides improved pharmacokinetic parameters due to an extended and constant in vivo release including substantial decreased peak concentrations, despite increased bioavailability, substantial extended times for maximal concentration, and higher minimal concentrations when compared with conventional immediate release dosage forms and a recent modified release tacrolimus dosage form.
    Type: Application
    Filed: December 26, 2013
    Publication date: June 26, 2014
    Applicant: Veloxis Pharmaceuticals A/S
    Inventors: Robert D. Gordon, Per Holm, Anne-Marie Lademann, Tomas Norling
  • Bidirectional type checking for declarative data scripting language
    Patent number: 8762942
    Abstract: An efficient, logical and expressive type system supports the combination of refinement types and type membership expressions, as well as a top type that encompasses all valid values as members. A bidirectional type checking algorithm is provided for the type system including synthesis and checking steps to statically verify types of code based on the type system.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: June 24, 2014
    Assignee: Microsoft Corporation
    Inventors: David E. Langworthy, Gavin Bierman, Andrew D. Gordon, Donald F. Box, Bradford H. Lovering, Jeffrey C. Schlimmer, John D. Doty
  • HETEROCYCLIC NUCLEAR HORMONE RECEPTOR MODULATORS
    Publication number: 20140162985
    Abstract: The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
    Type: Application
    Filed: September 6, 2013
    Publication date: June 12, 2014
    Applicant: ABBVIE INC.
    Inventors: Andrew Burchat, Thomas D. Gordon, Kelly D. Mullen, David C. Ihle, Michael J. Morytko, Kevin P. Cusack, Gloria Y. Lo Schiavo, Lei Wang, Michael Friedman
  • Security Language Translations with Logic Resolution
    Publication number: 20140165139
    Abstract: Security language constructs may be translated into logic language constructs and vice versa. Logic resolution may be effected using, for example, the logic language constructs. In an example implementation, translation of a security language assertion into at least one logic language rule is described. In another example implementation, translation of a proof graph reflecting a logic language into a proof graph reflecting a security language is described. In yet another example implementation, evaluation of a logic language program using a deterministic algorithm is described.
    Type: Application
    Filed: February 13, 2014
    Publication date: June 12, 2014
    Applicant: Microsoft Corporation
    Inventors: Moritz Y. Becker, Blair B. Dillaway, Cedric Fournet, Andrew D. Gordon, Jason F. Mackay
  • ETHERNET FAULT MANAGEMENT SYSTEMS AND METHODS
    Publication number: 20140133289
    Abstract: Ethernet fault management systems and methods using programmable Type-Length-Value (TLV) offsets combine software-based Operations, Administration, and Maintenance (OAM) protocol support with hardware-based fault management support to delegate generation and processing of OAM protocol messages to hardware devices with the software-based protocol support used to program hardware based on fixed offsets in the OAM protocol messages. The hardware can be designed to be flexible since the hardware can be agnostic to the logic within the OAM protocol which would reside in the software. The Ethernet fault management systems and methods combine the flexibility of software-based approaches with the speed and efficiency of hardware-based approaches.
    Type: Application
    Filed: November 14, 2012
    Publication date: May 15, 2014
    Applicant: CIENA CORPORATION
    Inventors: Asheesh Jadav, Cory D. Gordon, Madhavi R. Joshi, Venkata Satya Mahesh Jetti, Sri Siri Vineela Kukkadapu, Kelly D. Fromm
  • MODELING DATA GENERATING PROCESS
    Publication number: 20140101090
    Abstract: There is provided a method and system for modeling a data generating process. The method includes generating a dyadic Bayesian model including a pair of probabilistic functions representing a prior distribution and a sampling distribution, and modeling a data generating process based on the dyadic Bayesian model using observed data.
    Type: Application
    Filed: October 8, 2012
    Publication date: April 10, 2014
    Applicant: Microsoft Corporation
    Inventors: Andrew D. Gordon, Thore Graepel, Aditya Nori, Sriram Rajamani, Johannes Borgstroem
  • Tacrolimus for improved treatment of transplant patients
    Patent number: 8685998
    Abstract: An extended release oral dosage form comprising as active substance tacrolimus or a pharmaceutically active analogue thereof for a once daily immunosuppressive treatment of a patient in need thereof, preferable a kidney or liver transplant patient. The dosage form releases the active substance over an extended period of time. It also provides improved pharmacokinetic parameters due to an extended and constant in vivo release including substantial decreased peak concentrations, despite increased bioavailability, substantial extended times for maximal concentration, and higher minimal concentrations when compared with conventional immediate release dosage forms and a recent modified release tacrolimus dosage form.
    Type: Grant
    Filed: July 7, 2009
    Date of Patent: April 1, 2014
    Assignee: Veloxis Pharmaceuticals A/S
    Inventors: Robert D. Gordon, Per Holm, Anne-Marie Lademann, Tomas Norling